We are harnessing the natural predatory behavior of Dictyostelid amoebae to end the overuse of antibiotics and provide a safer way to control pathogenic microbes.
Antimicrobial resistance poses a serious challenge to modern medicine, especially in intractable infections where bacteria often persist in antimicrobial-tolerant biofilms that conventional antibiotics can't penetrate. Our technology turns anti-biofilm compounds produced by Dictyostelids into a novel solution for treating biofilm-associated infections. By harnessing these natural predators and their evolved ability to hunt and consume microbes within biofilms, we introduce a new tool to reduce antibiotic resistance and address the rising threat of drug-resistant infections.
Antimicrobial resistance is one of the biggest threats to global health. Each year, millions are affected by infections that no longer respond to treatment.
AmebaGone is to end the overuse of antibiotics to provide a safer way to control pathogenic microbes. Our technology harnesses the natural predatory behavior of Dictyostelid amoebae to assist in infection treatment.
Get to know the talented individuals behind our success. At AmebaGone, our diverse team brings together expertise across science, medicine, and agriculture - backed by deep specialization in amoebic biocontrol. United by a shared mission, we're developing disruptive technology that challenges the conventional use of antibiotics and drives forward a safer, more effective approach to microbial control.
Join our mailing list to receive the latest updates on our research, product developments, and upcoming events. Be the first to know about our breakthroughs in antimicrobial technology.